English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Kacie Whaley
| Sep 1, 2017
Rare disease therapy company, Shire, making executive changes
Marian Johns
| Aug 29, 2017
Shire, MircoHealth partner on app for hemophilia patients
Nicholas Gueguen
| Aug 1, 2017
Immunodeficiency disease patients report higher quality of life with CUVITRU treatment
Erianne Leatherman
| May 22, 2017
Shire outlines ADHD research at American Psychiatric Association meeting
Robert Hadley
| Apr 7, 2017
FDA accelerates review for drug that treats blood-clotting disease
Gene Johnson
| Mar 5, 2017
Shire honors Rare Disease Day with launch of 'Rare Count'
Keri Carbaugh
| Feb 17, 2017
Shire provides latest data on Hunter's syndrome, Gaucher disease
Keri Carbaugh
| Jan 8, 2017
Shire names Clark non-executive director
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
Coalition warns against potential impact of H.R. 1 on patient healthcare access
